Page last updated: 2024-10-31

neostigmine and Stroke

neostigmine has been researched along with Stroke in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, AJ1
Zang, P1
Guo, JM1
Wang, W1
Dong, WZ1
Guo, W1
Xiong, ZG1
Wang, WZ1
Su, DF1

Other Studies

1 other study available for neostigmine and Stroke

ArticleYear
Involvement of acetylcholine-α7nAChR in the protective effects of arterial baroreflex against ischemic stroke.
    CNS neuroscience & therapeutics, 2012, Volume: 18, Issue:11

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Baroreflex; Brain Ischemia; Cells, Cultured; Male;

2012